Edit

Integrated

http://www.indidx.com/

Last activity: 17.07.2021

Active

Categories: DiagnosticsHealthTechITProduct

Integrated Diagnostics develops large-scale, blood-based molecular diagnostics that leverage advances in proteomics and genomics to detect disease at its earliest stage. It leverages emerging technologies to develop diagnostic products used by physicians and patients to manage complex and serious diseases like cancer, diabetes and Alzheimer's. The company’s products work through blood tests that can monitor tens to hundreds of disease markers simultaneously. Integrated Diagnostics is headquartered in Seattle, Washington.

Mentions

Location: United States, Washington, Seattle

Employees: 11-50

Total raised: $6.1M

Founded date: 2009

Investors 2

Date	Name	Website
25.07.2020	InterWest ...	interwest....
17.07.2021	Baird Capi...	bairdcapit...

Funding Rounds 1

Date	Series	Amount	Investors
06.01.2017	Series C	$6.1M	-

Mentions in press and media 25

Date	Title	Description
30.03.2021	INTEGRATED VENTURES, INC. Integrated Ventures, Inc :. Announces Pricing of $9.0 Million Registered Direct Offering	PHILADELPHIA, March 30, 2021 /PRNewswire/ -- Integrated Ventures, Inc. (OTC: INTV) (the "Company") announced today that it has entered into a securities purchase agreement with certain institutional investors to purchase approxima...
24.03.2021	Biodesix takes out $30M refinance loan	Lung cancer diagnostics developer Biodesix Inc. (Nasdaq: BDSX) has taken out a $30 million loan to refinance an earlier financing vehicle. In a filing with the U.S. Securities and Exchange Commission Wednesday morning, the Boulder company s...
02.11.2020	Biodesix IPO raises $72M	Lung cancer testing company Biodesix Inc. (Nasdaq: BDSX) raised about $72 million in proceeds last week from the firm’s initial public offering. The company previously said it hoped to raise as much as $79 million. The company offered 4 mil...
21.10.2020	Biodesix seeks to raise up to $79M in IPO	Lung cancer testing company Biodesix Inc. is seeking to raise as much as $79 million in its initial public offering and values itself at up to $500 million on the open market. In an updated S-1 filing with the U.S. Securities and Exchange C...
06.02.2018	Solar Integrated Roofing Corporation Announces January Revenues Exceed $1 Million	Solar Integrated Roofing Corporation (OTCPINK: SIRC) announced that revenues for January 2018 have exceeded $1 million for the first time. Company President David Savarese said, “Historically, January is usually a slower month than most. Bu...
06.01.2017	Term Sheet — Friday, January 6	CES, CMO, IPO, CAIO Unicorn Watch: Yesterday I interviewed Xiaomi CFO Shou Zi Chew, formerly a partner at DST Global. Xiaomi, valued at $45 billion, is at CES hoping to deliver on its promise of a broad tech ecosystem offering a variety of ...
06.01.2017	Integrated Diagnostics Raises $6.1M in Series C Funding	Integrated Diagnostics (Indi), a Seattle, WA-based molecular diagnostic company, raised $6.1m in Series C funding. Backers included Baird Capital and InterWest Partners. Co-founded in October 2009 by systems-biology pioneer Dr. Lee Hood, an...
30.11.2015	India: Patel Integrated Logistics raises nearly $3m from Frontline of Mauritius	Premium Mumbai-based Patel Integrated Logistics has raised nearly $3 million (about Rs 19 crore) from Mauritius-based asset manager Frontline Strategy Ltd to expand its ecommerce business, according to a BSE filing. Continue reading this st...
23.06.2015	Biodesix Raises Additional $11M in Series E Financing	Biodesix Inc., a Buolder, Co.-based molecular diagnostics company that researches, develops and commercializes rapid, blood-based tests for precision medicine in oncology, raised another $11m in Series E financing. Existing Biodesix shareho...
12.01.2015	Biodesix Raised Additional $12M in Series E Funding	Biodesix, Inc., a Boulder, Colo.-based molecular diagnostics company that develops and commercializes blood-based tests in oncology enabling physicians to make more precise diagnostic and therapeutic decisions, raised an additional $12m in ...
18.11.2014	Baird Capital Announces Close of $185M Venture Capital Fund IV	CHICAGO, Nov. 18, 2014 – Baird Capital, the direct private investment arm of Robert W. Baird & Co. (Baird), announced the final close of its fourth Venture Capital fund with a total of $185 million in committed capital, exceeding its in...
12.05.2014	Tacoma biotech Revalesio raising $40M to develop cures for inflammatory diseases	Tacoma may not be the first place you think of when biotechnology comes to mind, but one company from the city is raising some serious dough to help people affected by diseases like asthma, multiple sclerosis and Alzheimer’s. Revalesio, a 1...
30.04.2014	Investors wager $47M more on a blood test to curtail unnecessary lung biopsies and surgeries	It’s usually caught when lung nodules – small, oval-shaped growths in the lungs – appear in chest X-rays or CT scans. Most of the time, lung nodules are benign, especially if they’re very small. But a variety of factors including a person’s...
29.04.2014	Indi Announces $47.25 Million in Funding for Blockbuster Diagnostic	Baird Capital, the direct private investment arm of Robert W. Baird & Co., announced today that its Venture Capital group has led a Series B financing round for Integrated Diagnostics, a molecular diagnostics company pioneering the use ...
29.04.2014	Indi Raises $47.25M	Indi (Integrated Diagnostics), a Seattle, WA-based molecular diagnostics company pioneering the use of blood-based proteomic tests, raised $47.25m in funding. It came from the $30.25m closing of its Series B round and $17m in non-dilutive d...
29.04.2014	Seattle blood test startup Indi raises $47.25 million	Al Luderer Seattle’s life sciences industry is getting another boost. Integrated Diagnostics, a Seattle company developing blood-based proteomic tests, has raised $30.25 million in series B funding and $17 million in debt financing. Investo...
14.01.2014	Biodesix Raises Additional $6.1M in Series E Funding	Biodesix, Inc., a Boulder, CO-based molecular diagnostic company dedicated to personalizing medicine, raised an additional $6.1m in Series E funding. This added to the $8.3m first close of the round announced a month ago (read here) with pr...
02.12.2013	Biodesix Closes $8.3M Series E Equity Financing	Biodesix, a Boulder, CO-based molecular diagnostic company dedicated to personalizing medicine, closed an $8.3m Series E equity financing. New funds accounted for $4.3m and the remaining $4m came from the conversion of a convertible note. E...
23.09.2013	Indi Molecular Raises $1.5M For Antibody Startup	Culver City- and Seattle-based Indi Molecular, a startup developing a synthetic replacement for antibodies, has raised $1.5M in a seed funding round. The funding was led by InterWest Partners, and also included a number of un-named angel in...
20.09.2013	Indi Molecular Raises $1.5M in Seed Funding	Indi Molecular, a Culver City, CA-based developer of a synthetic replacement for antibodies, raised $1.5m in seed funding. The round was led by InterWest Partners, with participation from several angel investors. The company intends to use ...
12.04.2013	Biodesix Closes $8.8M Series D Financing	Biodesix, Inc., a Boulder, CO-based molecular diagnostics company advancing the development of innovative products for personalizing medicine, closed on $8.8m in Series D financing. Backers included unnamed existing shareholders. Led by CEO...
11.11.2010	Biodesix Receives $7.1M in Series C Financing Round; $1.4M in Grants	Biodesix Inc., a Broomfield, CO-based personalized medicine company focused on the development of diagnostic products, has raised $7.1m in Series C financing round. The investment was led by existing backers – which provided $5.1m – with pa...
26.04.2010	Integrated DNA Technologies Receives $12.0M of Senior Subordinated Debt	Integrated DNA Technologies, Inc., a Coralville, Iowa-based supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical developme...
14.10.2009	USA, Integrated Diagnostics Raises $30M in Series A Financing Round	Seattle, WA-based Integrated Diagnostics, a newly formed biotechnology company, raised $30m in its Series A financing round led by InterWest Partners, with participation from The Wellcome Trust and dievini Hopp Biotech holding. According to...
-	Investors wager $47M more on a blood test to curtail unnecessary lung biopsies and surgeries	Integrated Diagnostics has an interesting proposal for a blood test. Instead of telling doctors that lung cancer is present in a patient with lung nodules, it’s aiming to tell them when it’s not present. The Seattle-based company has just p...

Integrated

Investors 2

Funding Rounds 1

Mentions in press and media 25

Reviews 0